Back to News
Feb 11, 2026 8:10 AM

CorVent Medical Completes Common Stock Offering to Support Anticipated Launch of CorVision™ Remote Patient Monitoring (RPM) SaaS Platform

FARGO, N.D., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CorVent Medical, an innovative medtech company applying artificial intelligence (AI) and machine learning (ML) to improve outcomes for critically ill, ventilated patients, today announced that it has raised additional equity financing through a common stock offering. Since inception, the Company has raised a total of $53.2M in equity capital and $6.8M in non-dilutive funding including government grants. The proceeds of the financing, which was led by existing investors, are expected to fund the planned commercialization of the CorVision™ RPM intelligent ventilation software platform, as well as investments to support the continued commercial growth of its RESPOND™ ventilator, which received U.S. FDA clearance in the fourth quarter of 2024.

"We are ...